Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-7.05%
Change (1 year)
Categories
Catalyst Pharmaceuticals (CPRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.13 B
According to Catalyst Pharmaceuticals's latest financial reports the company has $0.13 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Catalyst Pharmaceuticals - Cash on Hand chart (from 2004 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.13 B | -53.87% |
| 2022-12-31 | $0.29 B | 56.01% |
| 2021-12-31 | $0.19 B | 36.35% |
| 2020-12-31 | $0.14 B | 48.41% |
| 2019-12-31 | $94.51 M | 76.73% |
| 2018-12-31 | $53.48 M | -36.34% |
| 2017-12-31 | $84.01 M | 107.92% |
| 2016-12-31 | $40.4 M | -30.81% |
| 2015-12-31 | $58.39 M | 48.69% |
| 2014-12-31 | $39.27 M | 65.64% |
| 2013-12-31 | $23.71 M | 53.79% |
| 2012-12-31 | $15.41 M | 155.71% |
| 2011-12-31 | $6.02 M | 10.12% |
| 2010-12-31 | $5.47 M | -29.62% |
| 2009-12-31 | $7.77 M | -33.89% |
| 2008-12-31 | $11.76 M | -26.2% |
| 2007-12-31 | $15.94 M | -21.98% |
| 2006-12-31 | $20.43 M | 2549.98% |
| 2005-12-31 | $0.77 M | 319.29% |
| 2004-12-31 | $0.18 M | |
| 2002-12-31 | $0.1 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 16,557.71% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 9,119.97% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 5,188.59% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.67 B | 1,117.89% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $32.46 M | -76.41% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.07 B | 680.18% | 🇺🇸 USA |